Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
NEW YORK, Dec. 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
http://www.reportlinker.com/p0739466/Europe-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Summary
GlobalData's new report, "Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the Europe Diabetes Care Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Diabetes Care Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, LifeScan, Inc., Medtronic, Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Diabetes Care Devices in Europe 12
3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 12
3.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13
3.3 Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17
3.4 Diabetes Care Devices, Europe, Company share (2009-2010) 20
4 Diabetes Care Devices In Germany 22
4.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22
4.2 Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27
4.3 Diabetes Care Devices, Germany, Distribution Share (2009-2010) 30
4.3.1 Glucose Monitoring, Germany, Distribution Share (2009-2010) 30
4.3.2 Insulin Delivery, Germany, Distribution Share (2009-2010) 30
4.4 Diabetes Care Devices, Germany, Company share (2009-2010) 31
4.4.1 Glucose Monitoring, Germany, Company share (2009-2010) 33
4.4.2 Insulin Delivery, Germany, Company share (2009-2010) 34
5 Diabetes Care Devices In France 36
5.1 Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36
5.2 Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41
5.3 Diabetes Care Devices, France, Distribution Share (2009-2010) 44
5.3.1 Glucose Monitoring, France, Distribution Share (2009-2010) 44
5.3.2 Insulin Delivery, France, Distribution Share (2009-2010) 44
5.4 Diabetes Care Devices, France, Company share (2009-2010) 45
5.4.1 Diabetes Care Devices, France, Company share (2009-2010) 45
5.4.2 Glucose Monitoring, France, Company share (2009-2010) 47
5.4.3 Insulin Delivery, France, Company share (2009-2010) 48
6 Diabetes Care Devices In Italy 50
6.1 Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50
6.2 Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55
6.3 Diabetes Care Devices, Italy, Distribution Share (2009-2010) 58
6.3.1 Glucose Monitoring, Italy, Distribution Share (2009-2010) 58
6.3.2 Insulin Delivery, Italy, Distribution Share (2009-2010) 58
6.4 Diabetes Care Devices, Italy, Company share (2009-2010) 59
6.4.1 Diabetes Care Devices, Italy, Company share (2009-2010) 59
6.4.2 Glucose Monitoring, Italy, Company share (2009-2010) 61
6.4.3 Insulin Delivery, Italy, Company share (2009-2010) 62
7 Diabetes Care Devices In Spain 64
7.1 Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64
7.2 Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67
7.3 Diabetes Care Devices, Spain, Distribution Share (2009-2010) 70
7.3.1 Glucose Monitoring, Spain, Distribution Share (2009-2010) 70
7.3.2 Insulin Delivery, Spain, Distribution Share (2009-2010) 70
7.4 Diabetes Care Devices, Spain, Company share (2009-2010) 71
7.4.1 Diabetes Care Devices, Spain, Company share (2009-2010) 71
7.4.2 Glucose Monitoring, Spain, Company share (2009-2010) 73
7.4.3 Insulin Delivery, Spain, Company share (2009-2010) 74
8 Diabetes Care Devices In United Kingdom 76
8.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 76
8.2 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82
8.3 Diabetes Care Devices, United Kingdom, Distribution Share (2009-2010) 85
8.3.1 Glucose Monitoring, United Kingdom, Distribution Share (2009-2010) 85
8.3.2 Insulin Delivery, United Kingdom, Distribution Share (2009-2010) 85
8.4 Diabetes Care Devices, United Kingdom, Company Share (2009-2010) 86
8.4.1 Diabetes Care Devices, United Kingdom, Company Share (2009-2010) 86
8.4.2 Glucose Monitoring, United Kingdom, Company Share (2009-2010) 88
8.4.3 Insulin Delivery, United Kingdom, Company Share (2009-2010) 89
9 Overview of Key Companies in Europe Diabetes Care Devices Market 91
9.1 F. Hoffmann-La Roche Ltd. 91
9.1.1 Company Overview 91
9.1.2 Share in the Europe Diabetes Care Devices Market 91
9.2 Sanofi 92
9.2.1 Company Overview 92
9.2.2 Share in the Europe Diabetes Care Devices Market 92
9.3 Novo Nordisk A/S 93
9.3.1 Company Overview 93
9.3.2 Share in the Europe Diabetes Care Devices Market 93
9.4 Eli Lilly and Company 94
9.4.1 Company Overview 94
9.4.2 Share in the Europe Diabetes Care Devices Market 94
9.5 LifeScan, Inc. 95
9.5.1 Company Overview 95
9.5.2 Share in the Europe Diabetes Care Devices Market 95
9.6 Medtronic, Inc. 96
9.6.1 Company Overview 96
9.6.2 Share in the Europe Diabetes Care Devices Market 96
9.7 Becton, Dickinson and Company 97
9.7.1 Company Overview 97
9.8 Bayer HealthCare AG 97
9.8.1 Company Overview 97
9.9 Abbott Laboratories 97
9.9.1 Company Overview 97
9.10 Ypsomed Holding AG 98
9.10.1 Company Overview 98
9.11 Animas Corporation 98
9.11.1 Company Overview 98
9.12 NIPRO CORPORATION 98
9.12.1 Company Overview 98
9.13 ARKRAY, Inc. 99
9.13.1 Company Overview 99
9.14 Terumo Corporation 99
9.14.1 Company Overview 99
9.15 B. Braun Melsungen AG 99
9.15.1 Company Overview 99
10 Diabetes Care Devices Market Pipeline Products 100
11 Financial Deals Landscape 103
11.1 Acquisition 103
11.1.1 Mediq Acquires PBG from Mentha Capital 103
11.2 Partnerships 104
11.2.1 Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 104
11.2.2 EyeSense Enters Into An Agreement With QIAGEN 105
12 Recent Developments 106
12.1 Strategy And Business Planning 106
12.1.1 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 106
12.1.2 Oct 13, 2011: Unisense Establishes US Headquarter 106
12.1.3 Aug 25, 2011: Novo Nordisk To Build New Corporate Center In Bagsvaerd, Denmark 106
12.1.4 Jul 25, 2011: LEUKOCARE And Sanofi Pasteur Sign Cooperation Agreement For Vaccine Stabilization 107
12.1.5 Jun 23, 2011: Roche Sets Up R&D Institute In France To Foster Collaborative Translational Research 107
12.1.6 Apr 04, 2011: Sanofi-aventis's European Generic Pharmaceuticals Businesses To Operate Under Unified Brand Name Zentiva 107
12.2 Government and Public Interest 108
12.2.1 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 108
12.3 Product News 108
12.3.1 Apr 06, 2010: Study Finds Gene Linking Lower Birth Weight And Type 2 Diabetes 108
13 Appendix 110
13.1 Definitions of Markets Covered in the Report 111
13.1.1 Diabetes Care Devices 111
13.2 Research Methodology 112
13.3 Secondary Research 112
13.4 Primary Research 113
13.5 Models 113
13.6 Forecasts 114
13.7 Expert Panels 114
13.8 GlobalData Consulting 114
13.9 Currency Conversion 115
13.10 Contact Us 115
13.11 Disclaimer 115
List of Tables
Table 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Table 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13
Table 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Table 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 16
Table 5: Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17
Table 6: Diabetes Care Devices, Europe, Category Volume (Units), Historic, 2003-2010 18
Table 7: Diabetes Care Devices, Europe, Category Volume (Units), Forecast, 2010-2017 19
Table 8: Diabetes Care Devices, Europe, Company share by Revenue ($m), USD Actual, 2009-2010 21
Table 9: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22
Table 10: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24
Table 11: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26
Table 12: Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27
Table 13: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2003-2010 28
Table 14: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2010-2017 29
Table 15: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
Table 16: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
Table 17: Diabetes Care Devices, Germany, Company share by Revenue ($m), USD Actual, 2009-2010 32
Table 18: Glucose Monitoring, Germany, Company share by Revenue ($m), USD Actual 2009-2010 33
Table 19: Insulin Delivery, Germany, Company share by Revenue ($m), USD Actual 2009-2010 35
Table 20: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36
Table 21: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010 38
Table 22: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 40
Table 23: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41
Table 24: Diabetes Care Devices, France, Category Volume (Units), Historic, 2003-2010 42
Table 25: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2010-2017 43
Table 26: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44
Table 27: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44
Table 28: Diabetes Care Devices, France, Company share by Revenue ($m), USD Actual, 2009-2010 46
Table 29: Glucose Monitoring, France, Company share by Revenue ($m), USD Actual 2009-2010 47
Table 30: Insulin Delivery, France, Company share by Revenue ($m), USD Actual 2009-2010 49
Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50
Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52
Table 33: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54
Table 34: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55
Table 35: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2003-2010 56
Table 36: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2010-2017 57
Table 37: Glucose Monitoring, Italy, Distribution Share by Revenue ($m), USD Actual, 2009-2010 58
Table 38: Insulin Delivery, Italy, Distribution Share by Revenue ($m), USD Actual, 2009-2010 58
Table 39: Diabetes Care Devices, Italy, Company share by Revenue ($m), USD Actual, 2009-2010 60
Table 40: Glucose Monitoring, Italy, Company share by Revenue ($m), USD Actual 2009-2010 61
Table 41: Insulin Delivery, Italy, Company share by Revenue ($m), USD Actual 2009-2010 63
Table 42: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64
Table 43: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Historic, 2003-2010 65
Table 44: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66
Table 45: Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67
Table 46: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2003-2010 68
Table 47: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2010-2017 69
Table 48: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70
Table 49: Insulin Delivery, Spain, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70
Table 50: Diabetes Care Devices, Spain, Company share by Revenue ($m), USD Actual, 2009-2010 72
Table 51: Glucose Monitoring, Spain, Company share by Revenue ($m), USD Actual 2009-2010 73
Table 52: Insulin Delivery, Spain, Company share by Revenue ($m), USD Actual 2009-2010 75
Table 53: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 77
Table 54: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 79
Table 55: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 81
Table 56: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82
Table 57: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 83
Table 58: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 84
Table 59: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 85
Table 60: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 85
Table 61: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USD Actual, 2009-2010 87
Table 62: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 88
Table 63: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 90
Table 64: Diabetes Care Devices Market Pipeline Products 100
Table 65: Mediq Acquires PBG From Mentha Capital 103
Table 66: Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 104
Table 67: EyeSense Enters Into An Agreement With QIAGEN 105
Table 68: USD to Local Currency, Europe, Average Exchange Rate 2003-2010 115
List of Figures
Figure 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Figure 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13
Figure 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Figure 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15
Figure 5: Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17
Figure 6: Diabetes Care Devices, Europe, Category Volume (Units), Historic, 2003-2010 18
Figure 7: Diabetes Care Devices, Europe, Category Volume (Units), Forecast, 2010-2017 19
Figure 8: Diabetes Care Devices, Europe, Company share (%), 2010 20
Figure 9: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22
Figure 10: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23
Figure 11: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25
Figure 12: Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27
Figure 13: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2003-2010 28
Figure 14: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2010-2017 29
Figure 15: Diabetes Care Devices, Germany, Company share (%), 2010 31
Figure 16: Glucose Monitoring, Germany, Company share (%), 2010 33
Figure 17: Insulin Delivery, Germany, Company share (%), 2010 34
Figure 18: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36
Figure 19: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37
Figure 20: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39
Figure 21: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41
Figure 22: Diabetes Care Devices, France, Category Volume (Units), Historic, 2003-2010 42
Figure 23: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2010-2017 43
Figure 24: Diabetes Care Devices, France, Company share (%), 2010 45
Figure 25: Glucose Monitoring, France, Company share (%), 2010 47
Figure 26: Insulin Delivery, France, Company share (%), 2010 48
Figure 27: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50
Figure 28: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51
Figure 29: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53
Figure 30: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55
Figure 31: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2003-2010 56
Figure 32: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2010-2017 57
Figure 33: Diabetes Care Devices, Italy, Company share (%), 2010 59
Figure 34: Glucose Monitoring, Italy, Company share (%), 2010 61
Figure 35: Insulin Delivery, Italy, Company share (%), 2010 62
Figure 36: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64
Figure 37: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Historic, 2003-2010 65
Figure 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66
Figure 39: Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67
Figure 40: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2003-2010 68
Figure 41: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2010-2017 69
Figure 42: Diabetes Care Devices, Spain, Company share (%), 2010 71
Figure 43: Glucose Monitoring, Spain, Company share (%), 2010 73
Figure 44: Insulin Delivery, Spain, Company share (%), 2010 74
Figure 45: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 76
Figure 46: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 78
Figure 47: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 80
Figure 48: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82
Figure 49: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 83
Figure 50: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 84
Figure 51: Diabetes Care Devices, United Kingdom, Company Share (%), 2010 86
Figure 52: Glucose Monitoring, United Kingdom, Company Share (%), 2010 88
Figure 53: Insulin Delivery, United Kingdom, Company Share (%), 2010 89
Figure 54: F. Hoffmann-La Roche Ltd., Company Share (%), Europe Diabetes Care Devices Market, 2010 91
Figure 55: Sanofi, Company Share (%), Europe Diabetes Care Devices Market, 2010 92
Figure 56: Novo Nordisk A/S, Company Share (%), Europe Diabetes Care Devices Market, 2010 93
Figure 57: Eli Lilly and Company, Company Share (%), Europe Diabetes Care Devices Market, 2010 94
Figure 58: LifeScan, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2010 95
Figure 59: Medtronic, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2010 96
Companies mentioned
F. Hoffmann-La Roche Ltd.
Sanofi
Novo Nordisk A/S
Eli Lilly and Company
LifeScan, Inc.
Medtronic, Inc.
Becton, Dickinson and Company
Bayer HealthCare AG
Abbott Laboratories
Ypsomed Holding AG
Animas Corporation
NIPRO CORPORATION
ARKRAY, Inc.
Terumo Corporation
B. Braun Melsungen AG
To order this report:
Pathology Industry: Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article